Cargando…
Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
BACKGROUND: The growing number of melanoma patients who need long-term surveillance increasingly exceeds the capacity of the dermatology workforce, particularly outside of metropolitan areas. Digital technologies that enable patients to perform skin self-examination and send dermoscopic images of le...
Autores principales: | Drabarek, Dorothy, Habgood, Emily, Ackermann, Deonna, Hersch, Jolyn, Janda, Monika, Morton, Rachael L, Guitera, Pascale, Soyer, H Peter, Collgros, Helena, Cust, Anne E, Saw, Robyn PM, Emery, Jon, Mar, Victoria, Dieng, Mbathio, Azzi, Anthony, Lilleyman, Alister, Bell, Katy JL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334935/ https://www.ncbi.nlm.nih.gov/pubmed/37632906 http://dx.doi.org/10.2196/40623 |
Ejemplares similares
-
Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
por: Drabarek, Dorothy, et al.
Publicado: (2022) -
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
por: Ackermann, Deonna M., et al.
Publicado: (2021) -
Acceptability of a Hypothetical Reduction in Routinely Scheduled Clinic Visits Among Patients With History of a Localized Melanoma (MEL-SELF): Pilot Randomized Clinical Trial
por: Drabarek, Dorothy, et al.
Publicado: (2023) -
Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance
por: Williams, Jake T. W., et al.
Publicado: (2022) -
Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0–II) melanoma
por: Thompson, Jake R, et al.
Publicado: (2022)